✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
vitamin K2 heart health — Vitamin K2 Heart Health. Read on for an evidence-backed guide covering everything you need to know.
Key Takeaways
- Vitamin K2 heart health benefits centre on one critical mechanism: activating matrix GLA protein (MGP), the body’s most powerful inhibitor of arterial calcification.
- The Rotterdam Study found that people with the highest vitamin K2 intake had a 50% lower risk of dying from cardiovascular disease — a finding that does not apply to vitamin K1.
- Most Western diets provide enough calcium but are dangerously low in vitamin K2, leaving roughly 30% of K2-dependent proteins inactive — meaning calcium can deposit in arteries instead of bones.
- The best food source by far is natto (fermented soybeans), but quality MK-7 supplements at 90–180 mcg daily have also shown benefit in clinical trials.
- One critical safety note: if you take warfarin or other vitamin K antagonist blood thinners, you must speak to your doctor before adding K2 — it can interfere with your medication.
Vitamin K2 heart health — most people have heard that calcium builds strong bones. Far fewer have heard that calcium, without the right director, can end up in all the wrong places — specifically, the walls of your arteries. That director is a fat-soluble vitamin most Western diets barely provide: vitamin K2. The evidence connecting vitamin K2 heart health benefits is not fringe science — it comes from major population studies spanning tens of thousands of people and at least one three-year randomized controlled trial.
Vitamin K2 heart health — here is the central problem: calcium supplementation is widespread. Roughly 43% of Americans and 70% of older women take calcium supplements regularly. Yet vitamin K2 intake in Western diets has dropped substantially since the 1950s. The result is a calcium surplus without the molecular machinery to direct it properly. Calcium pills may strengthen your skeleton — but without enough K2, they could simultaneously be stiffening your arteries. The growing scientific consensus around vitamin K2 heart health makes this imbalance increasingly hard to ignore.
Vitamin K2 heart health — by the end of this article, you will understand exactly how vitamin K2 protects your cardiovascular system, which foods and supplements actually deliver meaningful amounts, and why this vitamin deserves a place in the conversation alongside statins, blood pressure medication, and exercise. One key piece of advice — about a dangerous interaction with a very common medication — could be the most important thing you read today. If you have ever wondered why some people take calcium religiously and still develop arterial disease, vitamin K2 heart health research provides the missing piece of the puzzle.
What Is Vitamin K2 — and Why Does It Matter? — Vitamin K2 heart health Explained
Quick Answer: Vitamin K2 (menaquinone) is a fat-soluble vitamin that activates specific proteins responsible for directing calcium — sending it into bones and teeth where it strengthens your skeleton, and keeping it out of soft tissues like arteries where it causes dangerous calcification. Unlike its more famous cousin vitamin K1, which primarily supports blood clotting, K2’s cardiovascular benefits are unique and substantial.
Vitamin K2 heart health — vitamin K was discovered in the 1930s by Danish scientist Henrik Dam, who found that chickens on low-fat diets developed bleeding problems that resolved when vitamin K was restored. The “K” comes from the German word Koagulation — and for decades, that was the vitamin’s entire reputation. It helps blood clot. End of story.
But vitamin K is not a single molecule. It is a family, with two main branches. Vitamin K1 (phylloquinone) is produced by plants and algae — think green leafy vegetables. Vitamin K2 (menaquinone) is produced by bacteria and found in fermented foods, animal products, and certain cheeses. And within K2, there are subtypes — MK-4 through MK-13 — based on the length of their molecular side chain. The most important for vitamin K2 heart health is menaquinone-7, or MK-7, which has the longest half-life in the body and the strongest evidence for cardiovascular protection.
The reason vitamin K2 matters for your heart comes down to one protein: matrix GLA protein, or MGP. MGP is produced by the smooth muscle cells that line your artery walls. In its active form, MGP is the body’s most powerful inhibitor of vascular calcification — it literally scoops up calcium that would otherwise form hardened plaques inside your arteries. But here is the catch: MGP is born inactive. To work, it must be carboxylated — and the only molecule that can do that carboxylation is vitamin K2.
Without enough vitamin K2, a significant proportion of your MGP stays in its inactive form. Calcium drifts into artery walls unchecked. Over years and decades, this contributes to arterial stiffening — the same process that drives hypertension, heart failure, and cardiovascular events. The vitamin K2 heart health connection is not theoretical. It is measurable, and as you will see in the research section, the numbers are striking.
How Vitamin K2 Protects Your Arteries — Vitamin K2 heart health Explained
Quick Answer: Vitamin K2 activates two key proteins — matrix GLA protein (MGP), which prevents calcium from depositing in arteries, and osteocalcin, which binds calcium into the bone matrix. Together, these two proteins create what researchers sometimes call the “calcium paradox” solution: strong bones and flexible arteries, rather than the reverse.
Think of calcium in your body like water flowing through a city’s plumbing system. You want it in the right pipes (bones and teeth), not leaking into the walls of other structures (arteries, kidneys, soft tissues). Vitamin K2 is the valve system. MGP, once activated by K2, patrols the arterial walls and binds any calcium that starts to accumulate, preventing it from forming crystalline deposits. Meanwhile, osteocalcin — also activated by K2 — pulls calcium from the bloodstream and locks it into the hydroxyapatite crystals that give bone its strength.
The problem, elegantly stated in a 2015 review published in Integrative Medicine, is that modern diets are high in calcium and low in vitamin K2. When K2 is deficient, an estimated 30% of the body’s K2-dependent proteins remain inactive. Calcium supplementation in this state may worsen arterial calcification — a finding that helps explain the increased cardiovascular risk seen in some calcium supplement trials.
What happens when K2 is adequate: Activated MGP removes calcium from arterial walls arteries stay flexible pulse wave velocity (a measure of arterial stiffness) improves blood pressure is easier to control long-term cardiovascular risk falls.
What happens when K2 is deficient: Inactive MGP cannot clear calcium calcium-phosphate crystals accumulate in the arterial media layer arteries stiffen systolic blood pressure rises the heart must work harder risk of heart failure, stroke, and cardiovascular death increases.
This mechanism helps explain why vitamin K2 heart health benefits are specific to K2 and not K1. Vitamin K1 is preferentially transported to the liver, where it activates clotting factors. K2, particularly MK-7, circulates more widely and reaches the peripheral tissues — blood vessel walls, bone, cartilage — where MGP and osteocalcin need activation. K1 can do the job if present in very high doses, but at normal dietary levels, the division of labor is clear: K1 for coagulation, K2 for calcification control.
Vitamin K1 vs K2 — What Is the Difference? — Vitamin K2 heart health Explained
| Feature | Vitamin K1 (Phylloquinone) | Vitamin K2 (Menaquinone/MK-7) |
|---|---|---|
| Main dietary sources | Green leafy vegetables (spinach, kale, broccoli) | Fermented foods (natto), hard cheeses, egg yolks, liver |
| Primary function | Blood clotting (activates hepatic coagulation factors) | Calcium regulation — bone formation and arterial calcification inhibition |
| Absorption from food | ~10% from leafy greens | Better absorbed; MK-7 has long half-life (~3 days) |
| Tissue distribution | Mostly stays in the liver | Circulates to peripheral tissues (arteries, bone, cartilage) |
| Heart disease evidence | Weak or null in most studies | Strong — Rotterdam (50% CV death), EPIC (9% CHD per 10mcg) |
| Dietary contribution | ~90% of total vitamin K intake in Western diets | Minor — most Western diets provide <30mcg/day |
The practical implication is clear: eating spinach and kale gives you plenty of K1 for proper blood clotting, but it does very little for your arteries. If you want the vitamin K2 heart health benefits, you need K2 specifically — from fermented foods, animal products, or supplementation with MK-7.
What the Research Says
Research Spotlight: The Evidence for Vitamin K2 and Cardiovascular Protection
The findings on vitamin K2 heart health are built on a foundation of multiple large, long-term studies. Here are the key ones:
1. The Rotterdam Study (Geleijnse et al., 2004) The most frequently cited study on K2 and heart disease. This Dutch population study followed 4,807 healthy men and women over age 55 for up to 10 years. After adjusting for traditional risk factors, the researchers found that participants with the highest dietary vitamin K2 intake (≥32 mcg/day) had a 50% reduction in cardiovascular death related to arterial calcification, a 25% reduction in all-cause mortality, and significantly less severe aortic calcification. Critically, vitamin K1 intake showed no such association.
2. The EPIC Cohort (Gast et al., 2009) Among 16,057 women aged 49–70 in the European Prospective Investigation into Cancer and Nutrition, every additional 10 mcg of dietary vitamin K2 consumed daily was associated with a 9% reduction in coronary heart disease incidence over 8 years of follow-up. The association was specific to K2 subtypes MK-7, MK-8, and MK-9. Again, vitamin K1 showed no protective effect.
3. Beulens et al. (2009) — Coronary Calcification Study This study of 564 postmenopausal women used CT scanning to directly measure coronary artery calcium. Women with the highest intake of vitamin K2 (specifically MK-7 through MK-9) had significantly less coronary calcification than those with low intake. The relationship was dose-dependent and independent of other cardiovascular risk factors.
4. Knapen et al. (2007) — Three-Year Randomized Trial This was the key intervention study. Researchers gave 244 postmenopausal women 180 mcg of vitamin K2 as MK-7 (MenaQ7) daily for 3 years. Results showed improved bone mineral density and bone strength. A follow-up analysis (data pending publication as of the review’s writing) using ultrasound and pulse-wave velocity measurements also showed significant improvement in arterial elasticity — carotid artery distensibility improved, and age-related arterial stiffening was significantly reduced in the K2 group compared to placebo. This remains one of the few randomized trials directly measuring vitamin K2 heart health outcomes.
| Study | Population | Key Finding | Strength |
|---|---|---|---|
| Rotterdam Study (2004) | 4,807 adults ≥55, 10yr follow-up | 50% CV death, 25% all-cause mortality with high K2 intake | Large, long-term, adjusted for confounders |
| EPIC Cohort (2009) | 16,057 women, 8yr follow-up | 9% CHD per 10mcg/day K2 | Very large sample, prospective |
| Beulens (2009) | 564 postmenopausal women | Significantly less coronary calcification with high K2 intake | Direct imaging of calcification |
| Knapen RCT (2007) | 244 postmenopausal women, 3yr | Improved vascular elasticity (180mcg/day MK-7) | Randomized controlled trial |
Best Food Sources of Vitamin K2
If you want to increase your vitamin K2 intake through diet, you need to know where to look — and what to avoid confusing with meaningful sources. Here is a practical ranking:
Highest (excellent sources):
- Natto (fermented soybeans): ~1,100 mcg K2 (MK-7) per 100g. A single tablespoon can provide hundreds of micrograms. This is by far the richest dietary source. The taste is an acquired one — earthy, strong, with a stringy texture — but it is the gold standard for dietary K2.
- Goose liver pâté: ~370 mcg per 100g. Not an everyday food, but vastly richer than chicken or beef liver.
Good sources:
- Hard aged cheeses (Gouda, Edam, Emmental): ~50–75 mcg per 100g. The fermentation and aging process is what creates the K2 — soft fresh cheeses like mozzarella or cream cheese contain negligible amounts.
- Egg yolks: ~15–30 mcg per yolk (pasture-raised tend to have more). Egg yolks are a practical daily source.
- Chicken (dark meat): ~10–15 mcg per 100g.
Modest sources:
- Butter: ~15 mcg per 100g — modest, and variable by season.
- Sauerkraut and kimchi: Variable — fermentation matters. K2 content depends on the specific bacterial strains used.
What about vitamin K1 sources? Spinach, kale, and broccoli are rich in K1 — great for blood clotting, but they do not contribute meaningfully to vitamin K2 heart health. Only about 10% of dietary K1 is absorbed, and what is absorbed preferentially goes to the liver, not the arteries.
If you are not eating natto or generous amounts of aged cheese regularly, you are almost certainly not getting enough K2 from diet alone for cardiovascular protection. This is why supplementation is a reasonable consideration — and what the clinical trials used.
The Calcium–K2 Connection
The relationship between calcium and vitamin K2 is the single most important concept in vitamin K2 heart health — and probably the most misunderstood. Here it is in one sentence: calcium strengthens bones, but without vitamin K2 to direct it, that same calcium can accumulate in your arteries and increase your cardiovascular risk.
This is not speculation. The Women’s Health Initiative found that women taking 1,000 mg/day of calcium supplements (with or without vitamin D) had a 15–22% increased risk of cardiovascular events — particularly in women who had not been taking calcium before the study. The EPIC-Heidelberg study found an 86% higher heart attack risk in regular calcium supplement users. A meta-analysis of kidney disease patients linked calcium-based phosphate binders with a 22% increase in cardiovascular death.
The likely explanation, as reviewed comprehensively by Maresz (2015), is that high-dose calcium supplementation temporarily elevates serum calcium — and when MGP is under-activated due to K2 deficiency, that calcium has nowhere safe to go except into arterial walls. This mechanism is at the core of the vitamin K2 heart health hypothesis: adequate K2 keeps MGP active, keeping calcium in bones and out of arteries. Calcium with adequate K2 is a bone-builder. Calcium without K2 may be an artery-stiffener.
This does not mean you should stop taking calcium if your doctor has recommended it. It means that if you take calcium, you should also pay attention to your vitamin K2 status. Adequate K2 intake — at least 32 mcg/day for basic protection, and ideally 90–180 mcg for cardiovascular support — may mitigate the risks associated with calcium supplementation while preserving the bone benefits.
How Much Vitamin K2 Do You Need?
Dosage recommendations for vitamin K2 are still evolving, but the clinical evidence offers clear guidance:
- Minimum protective intake: ~32 mcg/day. This is the threshold identified in the Rotterdam Study — above this level, cardiovascular death risk dropped by 50%.
- General health / maintenance: 45–90 mcg/day of MK-7. This is what many quality supplements provide and is supported by the EPIC study data.
- Cardiovascular support: 90–180 mcg/day of MK-7. The Knapen randomized trial used 180 mcg/day and demonstrated measurable improvements in arterial elasticity over 3 years.
- Therapeutic use (under medical supervision): 180–360 mcg/day. Higher doses have been studied and appear safe, but the evidence for additional benefit above 180 mcg is limited.
The form matters. MK-7 (menaquinone-7) has a half-life of approximately 3 days in the bloodstream, compared to roughly 1–2 hours for MK-4. This means MK-7 provides stable, sustained activation of MGP and osteocalcin. Most supplements marketed for vitamin K2 heart health use MK-7, often derived from natto fermentation.
Vitamin K2 is fat-soluble, so take it with a meal that contains some fat for optimal absorption. It can be taken at any time of day — there is no evidence that timing affects efficacy.
Who Should Be Cautious?
Vitamin K2 interacts with warfarin and other vitamin K antagonist anticoagulants. If you take warfarin (Coumadin), the addition of vitamin K2 can affect your INR — the measure of how thin your blood is. Warfarin works by blocking vitamin K recycling, so any change in vitamin K intake can alter its effectiveness. This does not mean you cannot take K2 if you are on warfarin — some doctors prescribe it deliberately — but it does mean you must work with your doctor, monitor your INR closely, and not make changes on your own.
This interaction does not apply to the newer oral anticoagulants (NOACs) such as apixaban, rivaroxaban, dabigatran, or edoxaban. These drugs work through different mechanisms and are not affected by vitamin K intake. If you take a NOAC, the K2 interaction concern does not apply to you — though you should still mention any supplements to your doctor.
Other considerations:
- Pregnancy and breastfeeding: K2 is present in breast milk and is important for fetal development. No safety concerns at dietary intake levels, but high-dose supplementation should be discussed with your obstetrician.
- Children: No specific concerns. K2 is present in dairy and is important for bone development. Supplementation is rarely necessary in healthy children.
- Kidney disease: Patients on dialysis often have profound K2 deficiency and accelerated vascular calcification. Some research suggests K2 supplementation may be particularly beneficial in this population, but dosing should be managed by a nephrologist.
Frequently Asked Questions
Q: What does vitamin K2 do for the heart?
A: Vitamin K2 heart health benefits come from activating matrix GLA protein (MGP), which prevents calcium from depositing in artery walls. Without active MGP, calcium accumulates in arteries, causing them to stiffen — a process called vascular calcification that raises blood pressure and increases the risk of heart attack, stroke, and heart failure. K2 is the only known cofactor for MGP activation.
Q: How much vitamin K2 should I take daily for heart health?
A: Clinical evidence suggests at least 32 mcg/day for basic cardiovascular protection (Rotterdam Study threshold) and 90–180 mcg/day of MK-7 for more active arterial health support (per the Knapen randomized trial). Most multivitamins contain little to no K2, so a dedicated MK-7 supplement is typically needed to reach these levels.
Q: Can vitamin K2 reverse arterial calcification?
A: Animal studies suggest that high vitamin K2 intake can partially reverse existing arterial calcification by activating MGP, which then removes calcium from vessel walls. Human data is less definitive — the randomized trials show slowing or halting of calcification progression rather than dramatic reversal. The strongest case for K2 is prevention: preventing calcification from developing in the first place.
Q: What foods are highest in vitamin K2?
A: Natto (fermented soybeans) is dramatically the richest source, with approximately 1,100 mcg of MK-7 per 100g. Other good sources include goose liver, hard aged cheeses (Gouda, Edam), egg yolks, and dark-meat chicken. Most Western diets provide less than 30 mcg/day from these sources combined.
Q: Is vitamin K2 the same as vitamin K?
A: No. Vitamin K is a family that includes K1 (phylloquinone, from plants, supports blood clotting) and K2 (menaquinone, from bacteria and fermentation, supports bone and cardiovascular health). The K2 form, particularly MK-7, is the one with the strongest evidence for cardiovascular protection.
Q: Can I get enough K2 from a multivitamin?
A: Probably not. Most standard multivitamins contain only vitamin K1, or no vitamin K at all. Those that do include K2 typically provide 10–20 mcg, which is below the 32 mcg/day threshold associated with cardiovascular benefit in the Rotterdam Study. A dedicated MK-7 supplement is more reliable.
Q: Does vitamin K2 interact with blood thinners?
A: Yes — but only with warfarin and related vitamin K antagonist anticoagulants. K2 can alter INR levels. If you take a newer blood thinner (NOAC/DOAC) such as apixaban, rivaroxaban, or dabigatran, vitamin K2 does not interfere with your medication. Always consult your prescribing doctor before adding any supplement.
Q: What is the difference between MK-4 and MK-7?
A: Both are forms of vitamin K2, but MK-7 has a much longer half-life in the body (~3 days vs ~1–2 hours for MK-4), which means it provides more sustained activation of K2-dependent proteins. Most of the cardiovascular outcome data — the Rotterdam and EPIC studies — specifically examined longer-chain menaquinones (MK-7 through MK-9), not MK-4.
Related Reading
- Managing blood pressure through lifestyle and medication
- Understanding cholesterol and lipids — the full picture
- Browse our complete vitamins and minerals guide
The Bottom Line
Vitamin K2 heart health benefits are not a nutritional fad — they are a well-documented biological mechanism backed by large population studies and at least one randomized trial. The Rotterdam Study’s finding of 50% lower cardiovascular death risk in people with adequate K2 intake, combined with the EPIC study’s 9% per-10-mcg dose-response relationship, makes a compelling case that this vitamin deserves far more attention than it currently receives.
The most important action you can take after reading this is a personal inventory: if you take calcium supplements, are you also getting enough vitamin K2? If your diet is low in fermented foods and aged cheeses, your intake is probably well below the protective threshold. An MK-7 supplement of 90–180 mcg/day is a straightforward, low-cost intervention with a favorable safety profile — provided you are not on warfarin. For anyone serious about long-term cardiovascular prevention, vitamin K2 heart health deserves a place alongside exercise, diet, and prescribed medications as a cornerstone of arterial protection.
Wondering how all of this fits into your broader cardiovascular prevention strategy? Read our guide on managing blood pressure through lifestyle and medication and our Cholesterol & Lipids education hub for the full picture.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Do not start, stop, or change any supplement or medication without consulting your doctor. Vitamin K2 can interact with warfarin and other anticoagulants — if you take a blood thinner, speak to your prescribing physician before adding K2.
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.